BIOXYNE LIMITED (BXN)

Biotechnology.

On this page you will find:

Company snapshot Delayed share price Company announcements Price history chart Exchange Traded Options

Company details Closing prices Dividends Warrants & Structured Products ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code	Last	% Chg	Bid	Offer	Open	High	Low	Vol
BXN	0.013	0%	0.009	0.015	0.000	0.000	0.000	0

BIOXYNE LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code	BXN
Securities	ASX Code, Security Description ------------------------------ BXN, Ordinary Fully Paid
Official Listing Date	14 December, 2000
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign?	No
Internet Address	http://www.bioxyne.com
Registered Office Address	Traverse Accountants, Level 4, 25 Lime Street, SYDNEY, NSW, AUSTRALIA, 2000
Head Office Telephone	(02) 9844 5422
Head Office Fax	(02) 9844 5445
Share Registry	COMPUTERSHARE INVESTOR SERVICES PTY LIMITED LEVEL 4, 60 CARRINGTON STREET, SYDNEY, NSW, AUSTRALIA, 2000
Share Registry Telephone	1300 787 272

Directors / Senior Management
Mr Anthony Peng Ho (Chairman, Non Exec. Director) Mr Phillip Edward Comans (CEO) Mr Jeremy Laurence Curnock Cook (Non Exec. Director) Mr Patrick Ford (Non Exec. Director) Mr Jarrod Travers White (CFO)

Company Secretary	Mr Jarrod Travers White Ms Laura Raymer
Principal Activities	Biotechnology.

BIOXYNE LIMITED announcements

How are company announcements published on www.asx.com.au?

Date	Price sens.	Headline	Pages	PDF
23/05/2013		Termination of proposed acquisition - Vitality Devices	2	PDF
30/04/2013		Appendix 4C - quarterly - 31 March 2013	7	PDF
04/04/2013		Appendix 3B - Quotation of Escrowed Stock	16	PDF
15/03/2013		Release of Shares from Escrow	1	PDF
07/03/2013		Appendix 3B and s708A(6) Notice - Completion of Placement	13	PDF
04/03/2013		Vitality Devices Acquisition Update	1	PDF
28/02/2013		Half Yearly Report and Accounts to 31 December 2012	21	PDF
20/02/2013		Completion of placement follow up	1	PDF
20/02/2013		Reinstatement to Official Quotation	1	PDF
20/02/2013		Completion of Placement	1	PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date	Last	% Change	High	Low	Vol *
22 May 2013	0.013	-13.33%	0.013	0.013	157,500
17 May 2013	0.015	0%	0.015	0.015	95,000
10 May 2013	0.015	7.14%	0.015	0.015	170,000
09 May 2013	0.014	16.67%	0.014	0.014	30,000
08 May 2013	0.012	0%	0.012	0.012	6,450

* Volume of shares shown represents only those shares traded on ASX.

BIOXYNE LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security BXN. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security BXN

Warrants & Structured Products

No warrants & Structured Products are available over the security BXN

ASX CFDs

No Contracts For Differences are available over the security BXN

MyASX: Login | Sign up